“We hope to start trials in India from May, with a few hundred patients, and expect to roll out the vaccine by September–October, if the trials are successful. We are planning to make the vaccine available at an affordable price of around Rs 1,000 in India, which will take into account costs (for us),” Serum Institute CEO and promoter
Adar Poonawallatold TOI.

Comments
Post a Comment
Please do not enter any spam link